Europe’s medical devices industry saw a drop of 15.38% in cross border deal activity during September 2022, when compared with the last 12-month average, led by DCC Healthcare’s $243.32m acquisition of Medi-Globe, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 22 medical devices industry cross border deals worth $400.9m were announced for the region in September 2022, against the 12-month average of 26 deals.

Of all the deal types, venture financing saw most activity in September 2022 with 13 transactions, representing a 59.1% share for the region.

In second place was M&A with eight deals, followed by private equity deals with one transactions, respectively capturing a 36.4% and 4.6% share of the overall cross border deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $243.32m, followed by venture financing deals totalled $157.54m.

Europe medical devices industry cross border deals in September 2022: Top deals

The top five medical devices cross border deals accounted for 88.2% of the overall value during September 2022.

The combined value of the top five medical devices cross border deals stood at $353.4m, against the overall value of $400.9m recorded for the month.

The top five medical devices industry cross border deals of September 2022 tracked by GlobalData were:

1) DCC Healthcare’s $243.32m acquisition deal with Medi-Globe

2) The $46.94m venture financing of TRiCares by 415 Capital Management, Andera Partners, BioMedPartners, Credit Mutuel Innovation, Go Capital , Karista and Wellington Partners Venture Capital

3) AXA Venture Partners, Bpifrance Financement, Karista, LBO France and Wille Finance’s $27.03m venture financing deal with Incepto Medical

4) The $20m venture financing of Your.MD by Canica, Orkla Ventures, Reckitt Benckiser Group and Smedvig Capital

5) General Catalyst Partners, Giant Ventures Global, KHP Ventures and SpeedInvest’s $16.11m venture financing deal with Doccla